92
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Iron oxide nanoparticles suppressed T helper 1 cell-mediated immunity in a murine model of delayed-type hypersensitivity

, , , &
Pages 2729-2737 | Published online: 05 Jun 2012

References

  • ItoAShinkaiMHondaHKobayashiTMedical application of functionalized magnetic nanoparticlesJ Biosci Bioeng2005100111116233845
  • HuberDLSynthesis, properties, and applications of iron nanoparticlesSmall20051548250117193474
  • GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials200526183995402115626447
  • HautotDPankhurstQAMorrisCMCurtisABurnJDobsonJPreliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patientsBiochim Biophys Acta200717721212517097860
  • LiuGMenPHarrisPLRolstonRKPerryGSmithMANanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalanceNeurosci Lett2006406318919316919875
  • BulteJWDouglasTWitwerBMagnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cellsNat Biotechnol200119121141114711731783
  • HammBStaksTTaupitzMContrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superpara-magnetic iron oxideJ Magn Reson Imaging1994456596687981510
  • VoglTJHammerstinglRPegiosWThe value of the livers-pecific superparamagnetic contrast medium AMI-25 for the detection and differential diagnosis of primary liver tumors versus metastasesRofo19941604319328 German8161744
  • JosephsonLLewisJJacobsPHahnPFStarkDDThe effects of iron oxides on proton relaxivityMagn Reson Imaging1988666476532850434
  • McLachlanSJMorrisMRLucasMAPhase I clinical evaluation of a new iron oxide MR contrast agentJ Magn Reson Imaging1994433013078061425
  • ReimerPMullerMMarxCT1 effects of a bolus-injectable super-paramagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration – preliminary clinical experience with dynamic T1-weighted MR imagingRadiology199820938318369844683
  • WangJChenYChenBPharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in miceInt J Nanomedicine2010586186621042548
  • LunovOSyrovetsTBucheleBThe effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophagesBiomaterials201031195063507120381862
  • HsiaoJKChuHHWangYHMacrophage physiological function after superparamagnetic iron oxide labelingNMR Biomed200821882082918470957
  • ParkEJKimHKimYYiJChoiKParkKInflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in miceToxicology20102751–3657120540983
  • ChenBAJinNWangJThe effect of magnetic nanoparticles of Fe(3)O(4) on immune function in normal ICR miceInt J Nanomedicine2010559359920856834
  • WangJChenBJinNThe changes of T lymphocytes and cytokines in ICR mice fed with Fe3O4 magnetic nanoparticlesInt J Nanomedicine2011660561021674017
  • ShenCCLiangHJWangCCLiaoMHJanTRA role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expressionInt J Nanomedicine201162791279822114506
  • ShenCCWangCCLiaoMHJanTRA single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c miceInt J Nanomedicine201161229123521753874
  • CherDJMosmannTRTwo types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clonesJ Immunol198713811368836942953788
  • MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
  • JanTRSuSTWuHYLiaoMHSuppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c miceInt Immunopharmacol20077677378017466911
  • BlankFGerberPRothen-RutishauserBBiomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cellsNanotoxicology20115460662121231795
  • NaqviSSamimMAbdinMConcentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stressInt J Nanomedicine2010598398921187917
  • ReimerPBalzerTFerucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applicationsEur Radiol20031361266127612764641
  • Resovist® [package insert]BerlinBayer Schering Pharma AG2002
  • ZhuMTFengWYWangBComparative study of pulmonary responses to nano- and submicron-sized ferric oxide in ratsToxicology20082472–310211118394769
  • KobayashiKKanedaKKasamaTImmunopathogenesis of delayed-type hypersensitivityMicrosc Res Tech200153424124511340669
  • YamashitaKSakaiMTakemotoNAttenuation of delayed-type hypersensitivity by fullerene treatmentToxicology20092611–2192419376187